• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[无家可归人群潜伏性结核病的治疗。两种治疗方法的比较]

[Treatment of latent tuberculosis among homeless population. Comparison between wo therapeutic approaches].

作者信息

Sánchez-Arcilla Ignacio, Vílchez José María, García de la Torre Manuel, Fernández Xiomara, Noguerado Arturo

机构信息

Programa de Prevención y Control de la Tuberculosis. Ayuntamiento de Madrid. Madrid. Spain.

出版信息

Med Clin (Barc). 2004 Jan 24;122(2):57-9. doi: 10.1016/s0025-7753(04)74140-8.

DOI:10.1016/s0025-7753(04)74140-8
PMID:14733856
Abstract

BACKGROUND AND OBJECTIVE

We aimed to compare treatment adherence and toxicity of isoniazide (H) (6 months) compared with rifampicine (R) + pirazinamide (Z) (2 months) in homeless patients in latent tuberculous infection (LTBI).

PATIENTS AND METHOD

Randomized and controlled prospective study.

RESULTS

We included 172 patients (116 males and 56 females) with an age average of 42.3 (12.8) years; 31 (18%) had recent conversion and 72 (41.8%) had some risk factor of hepatotoxicity. Both bivariate and multivariate analysis (p < 0.001; OR = 5.15 [2.34-11.35]) showed that the treatment was completed by 61.5% of patients administered the R+Z regimen, while it was completed only by 28.2% of those administered H for 6 months. Moreover, treatment was completed by 48.4% of Spanish or foreign patients with legal residence, while it was completed only by 28.6% of immigrant patients with no legal residence (p = 0.044 in bivariate analysis).

CONCLUSIONS

The R+Z regimen for 2 months as treatment of LTBI in homeless patients displays a higher adherence than H for 6 months. There were no differences in toxicity.

摘要

背景与目的

我们旨在比较异烟肼(H)(6个月)与利福平(R)+吡嗪酰胺(Z)(2个月)对潜伏性结核感染(LTBI)无家可归患者的治疗依从性和毒性。

患者与方法

随机对照前瞻性研究。

结果

我们纳入了172例患者(116例男性和56例女性),平均年龄42.3(12.8)岁;31例(18%)近期有结核菌阳转,72例(41.8%)有肝毒性危险因素。双变量和多变量分析均显示(p < 0.001;OR = 5.15 [2.34 - 11.35]),接受R+Z方案治疗的患者中有61.5%完成了治疗,而接受H治疗6个月的患者中仅有28.2%完成了治疗。此外,有合法居留身份的西班牙或外国患者中有48.4%完成了治疗,而无合法居留身份的移民患者中仅有28.6%完成了治疗(双变量分析中p = 0.044)。

结论

在无家可归患者中,采用R+Z方案治疗LTBI 2个月的依从性高于采用H治疗6个月。毒性方面无差异。

相似文献

1
[Treatment of latent tuberculosis among homeless population. Comparison between wo therapeutic approaches].[无家可归人群潜伏性结核病的治疗。两种治疗方法的比较]
Med Clin (Barc). 2004 Jan 24;122(2):57-9. doi: 10.1016/s0025-7753(04)74140-8.
2
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.利福平与吡嗪酰胺对比异烟肼用于预防HIV感染者结核病:一项国际随机试验。艾滋病临床研究特里·贝恩社区项目、成人艾滋病临床试验组、泛美卫生组织及疾病控制与预防中心研究小组。
JAMA. 2000 Mar 15;283(11):1445-50. doi: 10.1001/jama.283.11.1445.
3
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.利福平与吡嗪酰胺短程疗法与异烟肼治疗潜伏性结核感染的比较:一项多中心临床试验
Ann Intern Med. 2002 Oct 15;137(8):640-7. doi: 10.7326/0003-4819-137-8-200210150-00007.
4
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.对家庭接触者采用每周一次利福喷汀/异烟肼或每日一次利福平/吡嗪酰胺治疗潜伏性结核。
Am J Respir Crit Care Med. 2006 Apr 15;173(8):922-6. doi: 10.1164/rccm.200512-1953OC. Epub 2006 Feb 10.
5
Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.吡嗪酰胺和利福平与异烟肼治疗潜伏性结核:完成率提高但肝毒性更大。
Chest. 2003 Jan;123(1):102-6. doi: 10.1378/chest.123.1.102.
6
Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons.监狱囚犯和无家可归者中潜伏性结核病的不良事件及治疗完成情况。
Chest. 2005 Apr;127(4):1296-303. doi: 10.1378/chest.127.4.1296.
7
Treatment of tuberculosis in Haiti.海地的结核病治疗。
Am J Public Health. 2001 Oct;91(10):1546-7. doi: 10.2105/ajph.91.10.1546.
8
Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.利福平与异烟肼治疗潜伏性结核的依从性改善及毒性降低:一项回顾性研究
Arch Intern Med. 2006 Sep 25;166(17):1863-70. doi: 10.1001/archinte.166.17.1863.
9
Present status of chemotherapy for tuberculosis.结核病化疗的现状
Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S347-52. doi: 10.1093/clinids/11.supplement_2.s347.
10
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.成人及儿童结核病和结核感染的治疗。美国胸科学会。
Monaldi Arch Chest Dis. 1994 Sep;49(4):327-45.

引用本文的文献

1
Efficacy and Safety of Different Drug Regimens for Tuberculosis Preventive Treatment: A Systematic Review and Meta-Analysis.不同药物方案用于结核病预防性治疗的疗效与安全性:一项系统评价和Meta分析
Cureus. 2023 Apr 26;15(4):e38182. doi: 10.7759/cureus.38182. eCollection 2023 Apr.
2
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.潜伏结核感染治疗指南:美国国家结核病控制协会和美国疾病预防控制中心 2020 年推荐意见。
MMWR Recomm Rep. 2020 Feb 14;69(1):1-11. doi: 10.15585/mmwr.rr6901a1.
3
Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses.
利福喷汀和异烟肼(3HP)与其他潜伏性结核感染治疗方案相比的疗效和完成率:一项网络荟萃分析的系统评价
BMC Infect Dis. 2017 Apr 11;17(1):265. doi: 10.1186/s12879-017-2377-x.
4
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.在有活动性结核病风险的HIV阴性人群中,利福霉素(利福平、利福布汀和利福喷汀)与异烟肼用于预防结核病的比较。
Cochrane Database Syst Rev. 2013 Jul 5;2013(7):CD007545. doi: 10.1002/14651858.CD007545.pub2.
5
Tuberculosis control in vulnerable groups.弱势群体中的结核病控制
Bull World Health Organ. 2008 Sep;86(9):733-5. doi: 10.2471/blt.06.038737.
6
Regimens of less than six months for treating tuberculosis.治疗结核病的疗程少于六个月的方案。
Cochrane Database Syst Rev. 2000;1999(2):CD001362. doi: 10.1002/14651858.CD001362.